News Search Results
Jul 14, 2025, 03:38 ET Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform
worldwide through early R&D collaboration models." About Illimis Therapeutics Illimis Therapeutics is a pioneering biotechnology company at the forefront of developing innovative therapies for challenging central nervous system (CNS) and immune-related diseases. The company's
More news about: Illimis Therapeutics
Jul 14, 2025, 03:00 ET Bridge Capture™ enables sensitive, scalable liquid biopsy in colorectal cancer pilot
TURKU, Finland, July 14, 2025 /PRNewswire/ -- Genomill Health, a biotechnology company pioneering simplified targeted library preparation for next-generation sequencing announces the results of a clinical pilot study published
More news about: Genomill Health
Jul 14, 2025, 03:00 ET Bridge Capture™ enables sensitive, scalable liquid biopsy in colorectal cancer pilot
TURKU, Finland, July 14, 2025 /PRNewswire/ -- Genomill Health, a biotechnology company pioneering simplified targeted library preparation for next-generation sequencing announces the results of a clinical pilot study published
More news about: Genomill Health
Jul 14, 2025, 02:43 ET MGI Tech Won Green World Award for Sustainable Contribution to Thai Mangroves Conservation Efforts
focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various
More news about: MGI Tech
Jul 14, 2025, 02:07 ET MGI Tech Won Green World Award for Sustainable Contribution to Thai Mangroves Conservation Efforts
focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various
More news about: MGI Tech
Jul 13, 2025, 22:42 ET Global Times: Readers' Reflections: Building BRICS into a primary channel for strengthening solidarity and cooperation among Global South nations: Egyptian scholar
initiatives like the BRICS Action Plan for Innovation Cooperation can stimulate technological progress, especially in artificial intelligence, biotechnology, and green energy. Collaborations with Chinese and Indian educational institutions can enhance Egypt's workforce
More news about: Global Times
Jul 13, 2025, 20:00 ET CARsgen Successfully Defends Its GPC3 CAR-T Patent at the EPO
On July 3, 2025, a U.S.-based biotechnology — the sole appellant among the original two opponents — formally withdrew its appeal against the EPO Opposition Division's earlier decision to maintain
More news about: CARsgen Therapeutics
Jul 12, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers - FTRE
global contract research organization ("CRO") that provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers. The Company claims to have the "scale and expertise to advise, design and deliver [its] customers' programs, projects
More news about: Pomerantz LLP
Jul 12, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers - PEPG
[Click here for information about joining the class action] PepGen is a clinical-stage biotechnology company that focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases.
More news about: Pomerantz LLP
Jul 12, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against 3D Systems Corporation and Certain Officers - DDD
Medicine Program focuses on "the use of additive manufacturing for human organ transplantation." Since 2018, 3D Systems has partnered with the biotechnology company United Therapeutics Corporation ("United") "with a long-term goal of developing the capability to 3D print lungs that will allow patients
More news about: Pomerantz LLP
Jul 11, 2025, 11:00 ET High-Speed Cable Market Size to Reach USD 24.99 billion in 2031, Growing at a CAGR of 10.2%, | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 11, 2025, 06:55 ET Personal Care Ingredients Market worth $17.00 billion by 2030 - Exclusive Report by MarketsandMarkets™
lifestyles and the rise of e-commerce, is contributing to increased product adoption across diverse geographies and demographics. Innovations in biotechnology, green chemistry, and cold processing technologies are facilitating the development of high-performance ingredients that align with clean beauty
More news about: MarketsandMarkets
Jul 10, 2025, 14:55 ET LevEllis, Inc. Announces the Launch of PROVOQUE™: A Revolutionary Regenerative Skincare Serum
PROVOQUE™, a groundbreaking regenerative skincare serum. This innovative physician dispensed medical grade skincare product utilizes advanced biotechnology to restore, repair, and renew the skin, setting a new standard in the skincare industry.
More news about: LevEllis
Jul 10, 2025, 11:54 ET REGENXBIO Announces Publication of Preclinical Results Demonstrating Functional Benefits of Novel Microdystrophin Construct in RGX-202 Investigational Gene Therapy for Duchenne Muscular Dystrophy
and independence, required support for breathing, cardiomyopathy and premature death. ABOUT REGENXBIO Inc.REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field
More news about: REGENXBIO Inc.
Jul 10, 2025, 11:42 ET Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
standardized process development and manufacturing operations. About IGI IGI is a global, fully integrated clinical-stage biotechnology company focused on developing innovative biologics in oncology. Headquartered in New York, NY, IGI is advancing
More news about: Ichnos Glenmark Innovation
Jul 10, 2025, 11:23 ET Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
standardized process development and manufacturing operations. About IGI IGI is a global, fully integrated clinical-stage biotechnology company focused on developing innovative biologics in oncology. Headquartered in New York, NY, IGI is advancing
More news about: Ichnos Glenmark Innovation
Jul 10, 2025, 11:00 ET BrainXell, Inc. Appoints Katherine Vega Stultz as Chief Executive Officer and Board Director
Wis., July 10, 2025 /PRNewswire/ -- BrainXell, Inc., a leading biotechnology company developing iPSC-based CNS disease models and regenerative cell therapies, announces the appointment of Katherine
More news about: BrainXell, Inc.
Jul 10, 2025, 10:07 ET Diagnostics Transformed: $37 Billion Immunoassay Market Evolves with AI, Miniaturization, and POC Growth, reports Kalorama Information
Group Inc., has been a trusted source of market intelligence in healthcare diagnostics for over 25 years. With a focus on in vitro diagnostics, biotechnology, medical devices, and pharmaceuticals, Kalorama is recognized for delivering evidence-based insights that inform global business strategies. Kalorama
More news about: Kalorama Information
Jul 10, 2025, 09:15 ET Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year
the world. Illumina ranked second overall in the United States, and third in the global Pharmaceuticals & Biotechnology Industry category. According to TIME's methodology, selections were based on more than 20 key performance indicators related to environmental,
More news about: Illumina, Inc.
Jul 10, 2025, 08:54 ET LG Debuts Next-Generation Precision Medical AI
pharmaceutical and biotech firms to drive innovation in AI-based drug development. LG Corporation Chairman and CEO Kwang-mo Koo has identified AI and biotechnology as strategic growth areas central to improving human health. Reflecting this vision, LG is accelerating efforts in AI–bio convergence through targeted
More news about: LG AI RESEARCH
Jul 10, 2025, 08:30 ET BRENIG THERAPEUTICS ANNOUNCES APPOINTMENTS OF DAVID L. LUCCHINO AS CEO AND TIEN DAM, M.D., AS CHIEF MEDICAL OFFICER, EXPANDS PIPELINE
Mass., July 10, 2025 /PRNewswire/ -- Brenig Therapeutics, a clinical-stage biotechnology company pioneering AI-powered small-molecule therapies for neurodegenerative diseases, today announced two key executive appointments. David
More news about: Brenig Therapeutics Inc.
Jul 10, 2025, 08:30 ET Oncolytics Biotech® to Host Key Opinion Leader Discussion Focusing on Pancreatic and Gastrointestinal Cancers
approximately 50 clinical trials and authored over 120 manuscripts. About Oncolytics Biotech Inc.Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized
More news about: Oncolytics Biotech® Inc.
Jul 10, 2025, 08:00 ET Kodiak Sciences to Host Investor R&D Day on July 16, 2025
July 10, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing, and commercializing transformative therapeutics, announced today it will host an investor R&D
More news about: Kodiak Sciences Inc.
Jul 10, 2025, 08:00 ET Transcend Therapeutics Receives Breakthrough Therapy Designation for TSND-201 (methylone) for the Treatment of PTSD
Transcend Therapeutics, a clinical-stage biotechnology company that develops medicines to treat neuropsychiatric diseases, today announced that the U.S. Food & Drug Administration (FDA) has granted
More news about: Transcend Therapeutics
Jul 10, 2025, 07:30 ET AbbVie and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
standardized process development and manufacturing operations. About IGI IGI is a global, fully integrated clinical-stage biotechnology company focused on developing innovative biologics in oncology. Headquartered in New York, NY, IGI is advancing
More news about: AbbVie